Invention Grant
- Patent Title: Phenoxyethyl cyclic amine derivatives and their activity as EP4 receptor modulators
-
Application No.: US15030888Application Date: 2014-12-11
-
Publication No.: US09776964B2Publication Date: 2017-10-03
- Inventor: Matthew Joseph Fisher , Steven Lee Kuklish , Peter Rudolph Manninen , Matthew Allen Schiffler , Alan M Warshawsky , Jeremy Schulenburg York
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Nelsen L. Lentz
- International Application: PCT/US2014/069743 WO 20141211
- International Announcement: WO2015/094902 WO 20150625
- Main IPC: C07D211/44
- IPC: C07D211/44 ; C07D211/60 ; C07D217/26 ; C07D221/04 ; C07D221/20 ; C07D207/16 ; C07D209/52 ; C07D207/04 ; C07D211/06
Abstract:
The present invention provides a compound of the Formula (I): wherein X, R, R1, R2, R3, R4, R5, R6, R7, R8, and R9 are as defined herein, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20160272585A1 Phenoxyethyl Cyclic Amine Derivatives and Their Activity as EP4 Receptor Modulators Public/Granted day:2016-09-22
Information query
